<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 29.1 - Urinary Stress Incontinence</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 29.1 - Urinary Stress Incontinence | MD3 SCP Cases">
  <meta name="description" content="A 52-year-old woman with involuntary urine leakage when coughing and exercising. Learn about stress urinary incontinence, pelvic floor dysfunction, conservative and surgical management.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case29_1.html">
  <meta property="og:title" content="Case 29.1 - Urinary Stress Incontinence">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="A 52-year-old woman with involuntary urine leakage when coughing and exercising. Learn about stress urinary incontinence, pelvic floor dysfunction, conservative and surgical management.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 29.1 - Urinary Stress Incontinence">
  <meta property="twitter:description" content="A 52-year-old woman with involuntary urine leakage when coughing and exercising. Learn about stress urinary incontinence, pelvic floor dysfunction, conservative and surgical management.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 29.1 – Urinary Stress Incontinence</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Urogynaecology | <strong>Setting:</strong> General Practice</p>

    <h2>Clinical Scenario</h2>
    <p>Mrs. Linda Evans, a 52-year-old postmenopausal woman, attends her GP with a 2-year history of involuntary urine leakage.</p>

    <p><strong>"I'm so embarrassed, doctor. I leak urine whenever I cough, sneeze, or exercise. It's gotten so bad I've stopped going to my Zumba classes. I have to wear pads every day now. It's really affecting my confidence."</strong></p>

    <h3>History</h3>
    <ul>
      <li><strong>Presenting complaint:</strong> Involuntary urine leakage with coughing, sneezing, laughing, and exercise for 2 years (gradually worsening)</li>
      <li><strong>Character:</strong> Small-to-moderate volume leakage, worse with physical exertion, no urgency, no nocturia</li>
      <li><strong>Associated symptoms:</strong> No dysuria, no haematuria, no frequency, no urgency, no feeling of incomplete emptying</li>
      <li><strong>Obstetric history:</strong> Para 3 (3 vaginal deliveries, largest baby 4.2kg, one forceps delivery, third-degree tear repaired)</li>
      <li><strong>Gynaecological history:</strong> Menopause aged 50, no HRT, no prolapse symptoms</li>
      <li><strong>Past medical history:</strong> Asthma (salbutamol inhaler), chronic cough (smoker)</li>
      <li><strong>Medications:</strong> Salbutamol inhaler PRN</li>
      <li><strong>Social history:</strong> Smokes 15 cigarettes/day (30 pack-years), BMI 32, works as a primary school teacher</li>
    </ul>

    <h3>Examination</h3>
    <ul>
      <li><strong>Abdominal examination:</strong> Soft, non-tender, no palpable masses, no organomegaly</li>
      <li><strong>Pelvic examination:</strong>
        <ul>
          <li><strong>Inspection:</strong> Atrophic vulvovaginal changes (postmenopausal), no visible prolapse at rest</li>
          <li><strong>Speculum:</strong> Mild anterior vaginal wall descent (cystocele) on Valsalva, no uterine prolapse, cervix healthy</li>
          <li><strong>Bimanual:</strong> Normal-sized anteverted uterus, no adnexal masses</li>
          <li><strong>Cough stress test (with full bladder):</strong> <strong>Positive</strong> - immediate small-volume urine leakage on coughing</li>
        </ul>
      </li>
      <li><strong>Neurological examination (lower limbs):</strong> Normal power, reflexes, and sensation</li>
    </ul>

    <h3>Investigations</h3>
    <ul>
      <li><strong>Urine dipstick:</strong> Negative for blood, protein, leucocytes, nitrites</li>
      <li><strong>Bladder diary (3 days):</strong> Daytime frequency 6-8 times, nocturia 0-1 times, no urgency episodes, leakage only with physical activity</li>
      <li><strong>Post-void residual volume (bladder scan):</strong> 25mL (normal &lt;50mL)</li>
    </ul>

    <h2>Questions</h2>

    <div class="question">
      <p><strong>1. What is the most likely diagnosis? Explain the pathophysiology of this condition and identify the key risk factors present in this patient.</strong></p>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Diagnosis: Stress Urinary Incontinence (SUI)</strong></p>

        <p><strong>Definition:</strong></p>
        <p><strong>Stress urinary incontinence</strong> = involuntary urine leakage on effort/physical exertion (coughing, sneezing, laughing, exercise) due to increased intra-abdominal pressure <strong>WITHOUT urgency</strong>.</p>

        <p><strong>Pathophysiology:</strong></p>
        <p>SUI occurs when intra-abdominal pressure exceeds urethral closure pressure, causing involuntary urine loss. Two main mechanisms:</p>
        <ul>
          <li><strong>1. Urethral hypermobility (most common):</strong> Weakness of pelvic floor muscles → loss of urethral support → bladder neck and proximal urethra descend during straining → ineffective urethral closure</li>
          <li><strong>2. Intrinsic sphincter deficiency (ISD):</strong> Direct damage to urethral sphincter mechanism → weak urethral closure even at rest</li>
        </ul>

        <p><strong>Risk Factors Present in This Patient:</strong></p>
        <table>
          <thead>
            <tr>
              <th>Risk Factor</th>
              <th>Mechanism</th>
              <th>Present in This Case?</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td><strong>Vaginal deliveries (Para 3)</strong></td>
              <td>Stretching/tearing of pelvic floor muscles and nerves (pudendal nerve damage)</td>
              <td><strong>✓ YES - 3 vaginal deliveries</strong></td>
            </tr>
            <tr>
              <td><strong>Large baby (4.2kg)</strong></td>
              <td>Increased risk of pelvic floor trauma</td>
              <td><strong>✓ YES</strong></td>
            </tr>
            <tr>
              <td><strong>Instrumental delivery (forceps)</strong></td>
              <td>Increased pelvic floor trauma</td>
              <td><strong>✓ YES</strong></td>
            </tr>
            <tr>
              <td><strong>3rd-degree perineal tear</strong></td>
              <td>Severe pelvic floor disruption</td>
              <td><strong>✓ YES</strong></td>
            </tr>
            <tr>
              <td><strong>Postmenopausal (oestrogen deficiency)</strong></td>
              <td>Loss of urethral mucosal seal, reduced urethral vascularity, tissue atrophy</td>
              <td><strong>✓ YES - menopause age 50</strong></td>
            </tr>
            <tr>
              <td><strong>Obesity (BMI 32)</strong></td>
              <td>Chronic increased intra-abdominal pressure</td>
              <td><strong>✓ YES</strong></td>
            </tr>
            <tr>
              <td><strong>Chronic cough (smoker, asthma)</strong></td>
              <td>Repeated raised intra-abdominal pressure</td>
              <td><strong>✓ YES</strong></td>
            </tr>
            <tr>
              <td><strong>Age (52 years)</strong></td>
              <td>Progressive collagen weakness, muscle atrophy</td>
              <td><strong>✓ YES</strong></td>
            </tr>
          </tbody>
        </table>

        <p><strong>Why This is SUI (Not Urge Incontinence):</strong></p>
        <ul>
          <li>✓ Leakage <strong>only with physical exertion</strong> (coughing, sneezing, exercise) - NO urgency</li>
          <li>✓ <strong>Positive cough stress test</strong> - immediate leakage on coughing</li>
          <li>✓ No frequency (6-8 times/day is normal), no nocturia, no urgency episodes on bladder diary</li>
          <li>✓ Multiple risk factors for pelvic floor weakness</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <p><strong>2. Outline your initial management plan for this patient, including conservative measures and when you would consider surgical intervention.</strong></p>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Initial Management of Stress Urinary Incontinence (NICE 2019 Guidelines)</strong></p>

        <p><strong>Step 1: Conservative Management (FIRST-LINE - Trial for 3 Months)</strong></p>

        <p><strong>A. Lifestyle Modifications:</strong></p>
        <ul>
          <li><strong>Weight loss:</strong> Target BMI &lt;30 (current BMI 32) - reduces intra-abdominal pressure
            <ul>
              <li>Evidence: 5-10% weight loss improves SUI by 50%</li>
            </ul>
          </li>
          <li><strong>Smoking cessation:</strong> Reduces chronic cough (chronic raised intra-abdominal pressure)</li>
          <li><strong>Caffeine reduction:</strong> Caffeine is a bladder irritant (though less relevant in SUI vs urgency)</li>
          <li><strong>Fluid advice:</strong> Aim 1.5-2L/day - avoid restriction (concentrated urine irritates bladder)</li>
          <li><strong>Treat chronic cough:</strong> Review asthma control, consider cough suppressants</li>
        </ul>

        <p><strong>B. Supervised Pelvic Floor Muscle Training (PFMT) - FIRST-LINE TREATMENT:</strong></p>
        <ul>
          <li><strong>Referral to specialist women's health physiotherapist</strong></li>
          <li><strong>Programme:</strong> At least 8 contractions, 3 times per day, for <strong>≥3 months</strong></li>
          <li><strong>Technique:</strong> Contract and lift pelvic floor muscles (as if stopping urine mid-flow), hold 10 seconds, relax 10 seconds</li>
          <li><strong>Evidence:</strong> 50-70% of women report improvement/cure with supervised PFMT</li>
          <li><strong>Adjuncts:</strong> Vaginal cones, biofeedback, electrical stimulation (if difficulty isolating pelvic floor muscles)</li>
        </ul>

        <p><strong>C. Vaginal Oestrogen (Postmenopausal Women):</strong></p>
        <ul>
          <li><strong>Indication:</strong> Vaginal atrophy (present in this case)</li>
          <li><strong>Options:</strong> Vaginal oestradiol cream (e.g., Ovestin), pessary (e.g., Vagifem), or ring (Estring)</li>
          <li><strong>Mechanism:</strong> Restores urethral mucosal seal, improves vascularity, increases urethral tone</li>
          <li><strong>Note:</strong> Does NOT treat SUI directly but improves urethral function and facilitates PFMT</li>
        </ul>

        <p><strong>D. Containment Products (Interim Measure):</strong></p>
        <ul>
          <li>Absorbent pads (patient already using - reassure this is acceptable while awaiting PFMT)</li>
          <li>Avoid relying on these as sole management</li>
        </ul>

        <p><strong>Step 2: Surgical Management (If Conservative Treatment Fails After 3-6 Months)</strong></p>

        <p><strong>Indications for Surgery:</strong></p>
        <ul>
          <li><strong>Failure of conservative treatment</strong> (inadequate improvement after ≥3 months supervised PFMT)</li>
          <li>Patient prefers surgical management</li>
          <li>Significant impact on quality of life</li>
          <li><strong>Prerequisite:</strong> Patient must be counselled on risks/benefits, complete bladder diary, exclude reversible causes</li>
        </ul>

        <p><strong>Surgical Options:</strong></p>

        <p><strong>A. Mid-Urethral Sling (MUS) - GOLD STANDARD SURGICAL TREATMENT:</strong></p>
        <ul>
          <li><strong>Retropubic (TVT - Tension-free Vaginal Tape):</strong>
            <ul>
              <li>Success rate 80-90% at 5 years</li>
              <li>Sling placed under mid-urethra, passed retropubically</li>
              <li>Higher risk bladder injury (4%) vs TOT</li>
            </ul>
          </li>
          <li><strong>Transobturator (TOT - Transobturator Tape):</strong>
            <ul>
              <li>Success rate 75-85% at 5 years (slightly lower than TVT)</li>
              <li>Sling passed through obturator foramen</li>
              <li>Lower risk bladder injury vs TVT, but higher groin pain risk</li>
            </ul>
          </li>
          <li><strong>Complications:</strong>
            <ul>
              <li>Bladder injury (3-5%), vaginal erosion (1-3%), voiding dysfunction (2-5%), de novo urgency (5-10%)</li>
              <li><strong>Mesh complications (rare but serious):</strong> Chronic pain, dyspareunia, erosion</li>
              <li><strong>MHRA warning 2018:</strong> Synthetic mesh should only be used when conservative options have failed, by specialist surgeons in designated centres</li>
            </ul>
          </li>
        </ul>

        <p><strong>B. Autologous Fascial Sling (Alternative if Mesh Declined):</strong></p>
        <ul>
          <li>Uses patient's own rectus fascia as sling material</li>
          <li>Avoids mesh complications but requires larger incision, longer recovery</li>
          <li>Similar efficacy to synthetic mesh</li>
        </ul>

        <p><strong>C. Colposuspension (Burch Procedure):</strong></p>
        <ul>
          <li>Sutures placed in paravaginal fascia to bladder neck, attached to iliopectineal ligament</li>
          <li>Can be open or laparoscopic</li>
          <li>Similar efficacy to MUS but more invasive, longer recovery, higher prolapse risk</li>
          <li>Now second-line (MUS preferred)</li>
        </ul>

        <p><strong>D. Urethral Bulking Agents (For Intrinsic Sphincter Deficiency):</strong></p>
        <ul>
          <li>Injection of bulking material (collagen, silicone) into urethral submucosa to increase urethral closure pressure</li>
          <li>Less effective than MUS (40-60% improvement), requires repeat injections</li>
          <li>Option for elderly/frail patients unsuitable for surgery</li>
        </ul>

        <p><strong>Management Plan for This Patient:</strong></p>
        <ol>
          <li><strong>Immediate:</strong> Refer to women's health physiotherapy for supervised PFMT (3-month trial)</li>
          <li><strong>Prescribe vaginal oestrogen</strong> (e.g., Ovestin cream) for vaginal atrophy</li>
          <li><strong>Lifestyle:</strong> Smoking cessation support, weight loss referral (dietician), optimize asthma control</li>
          <li><strong>Review in 3 months:</strong> If inadequate response → refer to urogynaecology for consideration of surgical options (likely TVT/TOT if patient willing)</li>
        </ol>
      </div>
    </div>

    <h2>Key Learning Points</h2>
    <div class="key-points">
      <ul>
        <li><strong>Stress urinary incontinence (SUI)</strong> = involuntary urine leakage on physical exertion (coughing, sneezing, exercise) <strong>WITHOUT urgency</strong> - due to pelvic floor weakness ± intrinsic sphincter deficiency</li>
        <li><strong>Risk factors:</strong> Vaginal deliveries (especially large babies, instrumental, perineal tears), obesity, menopause, chronic cough, age</li>
        <li><strong>Diagnosis is clinical:</strong> History + positive cough stress test on examination (immediate leakage on coughing with full bladder)</li>
        <li><strong>Differentiate from urge incontinence:</strong> SUI = leakage with exertion (no urgency), urge incontinence = leakage preceded by sudden urge to void</li>
        <li><strong>First-line treatment: Supervised pelvic floor muscle training (PFMT)</strong> for ≥3 months - 50-70% improve/cure</li>
        <li><strong>Lifestyle:</strong> Weight loss (if BMI >30), smoking cessation (chronic cough), treat constipation</li>
        <li><strong>Postmenopausal women:</strong> Add vaginal oestrogen to improve urethral function and vaginal atrophy</li>
        <li><strong>Surgery if conservative fails:</strong> Mid-urethral sling (TVT/TOT) = gold standard (80-90% success) - but MHRA warning re: mesh complications</li>
        <li><strong>Complications of mesh surgery:</strong> Chronic pain, erosion, dyspareunia - should only be used in specialist centres after conservative options exhausted</li>
        <li><strong>Red flags requiring urgent referral:</strong> Haematuria (exclude malignancy), pelvic mass, suspected fistula, failed previous surgery</li>
      </ul>
    </div>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/user-analytics.js"></script>
  <script src="../js/analytics-integration.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
